Chase Investment Counsel’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-29,012
Closed -$3.39M 104
2021
Q2
$3.39M Sell
29,012
-17,920
-38% -$2.15M 1.4% 27
2021
Q1
$5.17M Sell
46,932
-274
-0.6% -$29.8K 2.37% 8
2020
Q4
$4.73M Buy
47,206
+15,884
+51% +$1.47M 2.09% 12
2020
Q3
$2.45M Buy
+31,322
New +$2.36M 1.22% 34
2018
Q3
Sell
-8,040
Closed -$803K 94
2018
Q2
$803K Sell
8,040
-230
-3% -$24.3K 0.43% 50
2018
Q1
$873K Buy
+8,270
New +$836K 0.45% 52

Other funds holding EMN

Chase Investment Counsel's EMN Position: Q3 2021 in Review

Chase Investment Counsel sold out of Eastman Chemical (EMN) in Q3 2021, closing a stake of 29,012 shares — an estimated $3.39M sold.

Chase Investment Counsel first reported a position in EMN in Q1 2018 and held it in 6 quarters. The position peaked at $5.17M in Q1 2021. 706 funds tracked by Wall St. Rank hold EMN as of Q3 2021.

  • Chase Investment Counsel reported no remaining Eastman Chemical position as of Q3 2021 after selling out during the quarter.
  • Chase Investment Counsel sold 29,012 Eastman Chemical shares in Q3 2021, an estimated $3.39M.
  • Chase Investment Counsel first reported a position in Eastman Chemical in Q1 2018 and held it in 6 quarters.
  • Chase Investment Counsel's Eastman Chemical position peaked at $5.17M in Q1 2021.
  • 706 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2021.

Based on Chase Investment Counsel's 13F filing for Q3 2021, filed 4 Nov 2021.